DNAX accessory molecule‐1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Immunology

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.200838409PMID 19404979
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

  2008cited by this paper
• Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.

  2008cited by this paper
• Ecto-F1-ATPase and MHC-class I close association on cell membranes.

  2008cited by this paper
• The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.

  2007cited by this paper
• The roles of nectins in cell adhesions: cooperation with other cell adhesion molecules and growth factor receptors.

  2007cited by this paper
• Perspectives of gammadelta T cells in tumor immunology.

  2007cited by this paper
• Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity

  2007cited by this paper
• Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.

  2007cited by this paper
• DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.

  2007cited by this paper
• Both CD133+ and CD133– medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK‐mediated cytotoxicity

  2007cited by this paper
• Immunotherapy of hepatocellular carcinoma.

  2006cited by this paper
• Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.

  2006cited by this paper
• Human gamma delta T cells and tumor immunotherapy.

  2006cited by this paper
• The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.

  2006cited by this paper
• Activated γδ T cells express the natural cytotoxicity receptor natural killer p44 and show cytotoxic activity against myeloma cells

  2006cited by this paper
• Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I.

  2005cited by this paper
• Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy.

  2005cited by this paper
• V gamma 9V delta 2 T cell response to colon carcinoma cells.

  2005cited by this paper
• Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.

  2005cited by this paper
• PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.

  2005cited by this paper
• Cytotoxic effects of γδ T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy

  2005cited by this paper
• Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells1

  2005cited by this paper
• Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma1

  2005cited by this paper
• The LFA-1-associated Molecule PTA-1 (CD226) on T Cells Forms a Dynamic Molecular Complex with Protein 4.1G and Human Discs Large*

  2004cited by this paper
• Distinct subpopulations of gamma delta T cells are present in normal and tumor-bearing human liver.

  2004cited by this paper
• DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions

  2004cited by this paper
• Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).

  2004cited by this paper
• Cutting Edge: CD96 (Tactile) Promotes NK Cell-Target Cell Adhesion by Interacting with the Poliovirus Receptor (CD155)

  2004cited by this paper
• Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells

  2003cited by this paper
• Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule

  2003cited by this paper
• Immunotherapy in hepatocellular carcinoma.

  2000cited by this paper
• γδ T cells lyse autologous and allogenic oesophageal tumours: involvement of heat-shock proteins in the tumour cell lysis

  2000cited by this paper
• Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB

  1999cited by this paper
• Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.

  1999cited by this paper
• Physical and functional association of LFA-1 with DNAM-1 adhesion molecule.

  1999cited by this paper
• Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor.

  1998cited by this paper
• DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes.

  1996cited by this paper
• V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer.

  1995cited by this paper

• Uncovering the mysteries of human gamma delta T cells: from origins to novel therapeutics

  2025cites this paper
• Gamma delta T cells and their immunotherapeutic potential in cancer

  2025cites this paper
• Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cells

  2025cites this paper
• Diverse Subsets of γδT Cells and Their Specific Functions Across Liver Diseases

  2025cites this paper
• Understanding Liver Transplantation Outcomes Through the Lens of Its Tissue-resident Immunobiome.

  2025cites this paper
• The antiviral potential of Vγ9Vδ2 T cells: Therapeutic implications for immunocompromised adult and pediatric hosts.

  2025cites this paper
• Single-cell analysis of peripheral blood and pleural effusion reveals functional diversity of γδ T cells in tuberculosis infection

  2025cites this paper
• Disrupting the balance between activating and inhibitory receptors of γδT cells for effective cancer immunotherapy

  2025cites this paper
• Role of Innate Immunity in Cancer.

  2025cites this paper
• Gamma delta (γδ) T cells: origin, phenotype, functions

  2025cites this paper
• Gamma delta T cells: Multifaceted mediators in pregnancy and the pathogenesis of miscarriage.

  2025cites this paper
• Primordial Cells Bridging the Gap Between Innate and Adaptive Immunity.

  2025cites this paper
• Gamma Delta T Cells in Solid Organ Transplantation

  2025cites this paper
• Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapy.

  2024cites this paper
• Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements

  2024cites this paper
• Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia–Lymphoma

  2024cites this paper
• γδ T Cells: A Game Changer in the Future of Hepatocellular Carcinoma Immunotherapy

  2024cites this paper
• The role of the epithelial sentinels, Langerhans cells and γδT cells, in oral squamous cell carcinoma

  2024cites this paper
• γδ T cells as critical anti-tumor immune effectors

  2024cites this paper
• CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells

  2024cites this paper
• Function of gamma delta (γδ) T cell in cancer with special emphasis on cervical cancer.

  2023cites this paper
• Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen.

  2023cites this paper
• γδ T cells: origin and fate, subsets, diseases and immunotherapy

  2023cites this paper
• IL12/18/21 pre-activation enhances the anti-tumor efficacy of expanded γδT cells and overcomes resistance to anti-PD-L1 treatment.

  2023cites this paper
• EBV-induced T-cell responses in EBV-specific and nonspecific cancers

  2023cites this paper
• Clinical Significance of Nectins in HCC and Other Solid Malignant Tumors: Implications for Prognosis and New Treatment Opportunities—A Systematic Review

  2023cites this paper
• Local γδ T cells: translating promise to practice in cancer immunotherapy

  2023cites this paper
• Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions

  2023cites this paper
• The emerging roles of γδ T cells in cancer immunotherapy

  2023cites this paper
• Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives

  2022cites this paper
• Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2+ T Cells in the Presence of Costimulation by CD28 or NKG2D

  2022cites this paper
• Human allogenic γδ T cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands

  2022cites this paper
• Nature products of traditional Chinese medicine provide new ideas in γδT cell for tumor immunotherapy

  2022influential citation
• Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy

  2022cites this paper
• Controversial role of γδ T cells in pancreatic cancer.

  2022cites this paper
• A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma

  2022cites this paper
• The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?

  2021cites this paper
• Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application

  2021cites this paper
• The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma

  2021cites this paper
• Poliovirus receptor (PVR)-like protein cosignaling network: new opportunities for cancer immunotherapy

  2021cites this paper
• How to Train Your Dragon: Harnessing Gamma Delta T Cells Antiviral Functions and Trained Immunity in a Pandemic Era

  2021cites this paper
• Therapeutic Targeting of Checkpoint Receptors within the DNAM-1 Axis.

  2021cites this paper
• Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression

  2021cites this paper
• The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting

  2021cites this paper
• Diverse Functions of γδ T Cells in the Progression of Hepatitis B Virus and Hepatitis C Virus Infection

  2021cites this paper
• The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy

  2020cites this paper
• The Roles of γδ T Cells in Hematopoietic Stem Cell Transplantation

  2020cites this paper
• γδ T Cells as Immuno-Oncology Treatments in the Era of Precision Medicine

  2020cites this paper
• Role of γδ T Lymphocytes in Cancer Immunosurveillance and Immunotherapy

  2020cites this paper
• Overexpression of miR-382 Sensitizes Hepatocellular Carcinoma Cells to γδ T Cells by Inhibiting the Expression of c-FLIP

  2020cites this paper
• Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet

  2020cites this paper
• Intratumoral γδ T‐Cell Infiltrates, Chemokine (C‐C Motif) Ligand 4/Chemokine (C‐C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma

  2020cites this paper
• Development and Function of γδT Cells in the Oral Mucosa

  2020cites this paper
• Boosting the Immune System for HIV Cure: A γδ T Cell Perspective

  2020cites this paper
• The complex existence of γδ T cells following transplantation: the good, the bad and the simply confusing

  2019cites this paper
• Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma

  2019cites this paper
• Persistent gamma delta T‐cell dysfunction in chronic HCV infection despite direct‐acting antiviral therapy induced cure

  2019cites this paper
• Diminished cytolytic activity of γδ T cells with reduced DNAM-1 expression in neuroblastoma patients.

  2019cites this paper
• Derivation of mimetic γδ T cells endowed with cancer recognition receptors from reprogrammed γδ T cell

  2019cites this paper
• The immunobiology of human hepatic gamma delta T cells

  2018cites this paper
• γδ T cell-mediated individualized immunotherapy for hepatocellular carcinoma considering clinicopathological characteristics and immunosuppressive factors

  2018cites this paper
• Low-Density Lipoprotein Uptake Inhibits the Activation and Antitumor Functions of Human Vγ9Vδ2 T Cells

  2018cites this paper
• Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy

  2018cites this paper
• Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer

  2018cites this paper
• Molecular Determinants of Target Cell Recognition by Human γδ T Cells

  2018influential citation
• Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias

  2018influential citation
• γδ T cells in liver diseases

  2018cites this paper
• Imperatorin Targets MCL-1 to Sensitize CD133+ Lung Cancer Cells to γδ-T Cell-Mediated Cytotoxicity

  2018cites this paper
• Gamma/Delta T Cells and Their Role in Protection Against Malaria

  2018cites this paper
• Hepatocellular carcinoma : prospects for NK cell immunotherapy ?

  2018cites this paper
• Low-Density Lipoprotein uptake inhibits the activation and antitumor functions of human V  9V  2

  2018influential citation
• Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications

  2017cites this paper
• Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells

  2017cites this paper
• γδ T cell-based cancer immunotherapy.

  2017cites this paper
• The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity.

  2017cites this paper
• TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy

  2017cites this paper
• Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities

  2017cites this paper
• MiR‐892a Promotes Hepatocellular Carcinoma Cells Proliferation and Invasion Through Targeting CD226

  2017cites this paper
• Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy

  2016cites this paper
• Human γδT-cell subsets and their involvement in tumor immunity

  2016cites this paper
• Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate

  2016cites this paper
• Rapamycin enhances IFN-γ and IL-4 production in co-culture of gδ T and dendritic cells from mice with lipopolysaccharide-induced acute lung injury.

  2016cites this paper
• Regulatory and effector functions of gamma–delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer

  2016cites this paper
• Five Layers of Receptor Signaling in γδ T-Cell Differentiation and Activation

  2015cites this paper
• CD 226 gene polymorphisms are associated with non-small-cell lung cancer in the Chinese han population

  2015cites this paper
• Isopentenyl pyrophosphate secreted from Zoledronate-stimulated myeloma cells, activates the chemotaxis of γδT cells.

  2015cites this paper
• CD226 gene polymorphisms are associated with non-small-cell lung cancer in the Chinese Han population

  2015cites this paper
• NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors

  2015cites this paper
• γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes.

  2015cites this paper
• Loss of CD155 expression predicts poor prognosis in hepatocellular carcinoma

  2015cites this paper
• Human γδ T cell-based immunotherapy for breast cancer

  2015cites this paper
• Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy

  2015cites this paper
• γδ T cells as a potential tool in colon cancer immunotherapy.

  2014cites this paper
• Plasticity of γδ T Cells: Impact on the Anti-Tumor Response

  2014cites this paper
• A Comprehensive Analysis of Primary Acute Myeloid Leukemia Identifies Biomarkers Predicting Susceptibility to Human Allogeneic V&ggr;9V&dgr;2 T Cells

  2014cites this paper
• Les récepteurs de nectines/ DNAM-1 et CRTAM Immuno-surveillance ou échappement tumoral ?

  2014cites this paper
• [Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape].

  2014cites this paper
• Manipulating immune cells for adoptive immunotherapy of cancer.

  2014cites this paper
• CRTAM Receptor Engagement by Necl-2 on Tumor Cells Triggers Cell Death of Activated Vγ9Vδ2 T Cells

  2013cites this paper
• Open basic research question : why do blast cells of pediatric patients with ALL seem to be more susceptible to NK cell lysis than leukemia cells of adult ALL ?

  2013influential citation